ERBB2 and breast carcinoma: It was also shown that SLC31A1 was correlated with the histological subtype of breast cancer, as patients with aggressive TNBC and human epidermal growth factor-2 (HER2+) cancer subtypes had higher SLC31A1 expression than patients with luminal A and B cancer subtypes [130].